Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01536990 · ClinicalTrials.gov registry record
Sensitivity to Change of the Lower Extremity Functional Scale in Patients With Stroke
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 39
- Enrollment target
NCT01536990: Completed study, sponsored by Mayo Clinic.
NCT01536990 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 39 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01536990 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 39 participants
- Enrollment target
Study Summary
The purpose of this study was to investigate the reliability, construct validity, and sensitivity to change of the Lower Extremity Functional Scale (LEFS) in individuals affected by stroke.
Primary Outcome
Lower Extremity Function Scale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2007-05 |
| Est. Completion | 2011-01 |
What the finished NCT01536990 record still lists
NCT01536990 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 39 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01536990 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01536990 about?
NCT01536990 is a clinical study titled "Sensitivity to Change of the Lower Extremity Functional Scale in Patients With Stroke". The purpose of this study was to investigate the reliability, construct validity, and sensitivity to change of the Lower Extremity Functional Scale (LEFS) in individuals affected by stroke.
What is the current status of trial NCT01536990?
This trial is currently completed. The enrollment target is 39 participants. The study started on 2007-05. Estimated completion is 2011-01.
Who is sponsoring clinical trial NCT01536990?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465592 · 39 participants · Phase 1
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
- NCT03961776 · 39 participants
Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems
- NCT04050280 · 39 participants · Phase 2
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
- NCT04190862 · 39 participants · Phase 1
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia